-

SHAREHOLDER ALERT: Robbins LLP Reminds Investors that Canoo Inc. (GOEV) is Being Sued for Misleading Shareholders

SAN DIEGO & TORRANCE, Calif.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a purchaser of Canoo Inc. (f/k/a Hennessy Capital Acquisition Corp. IV) (NASDAQ: GOEV, GOEVW) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between August 18, 2020 and March 29, 2021.

If you suffered a loss due to Canoo Inc's misconduct, click here.

Canoo Inc. (GOEV) Misled Investors Regarding its Business Model

According to the complaint, Canoo Holdings Ltd., an electric vehicle company, became a public entity via merger with Hennessy Capital, a special purchase acquisition company, on December 21, 2020. The companies announced the merger on August 18, 2020, filing its Registration Statement on Form S-1 with the SEC the same day. The Registration Statement touted Canoo's engineering and technology services, noting that "[t]his business offers a unique opportunity to generate immediate revenues in advance of the offering of our first vehicle and our current pipeline in this area is supportive of a projected $120 million of revenue in 2021." The Registration Statement noted that Canoo's "[c]ontract engineering services offer a separate revenue stream" and that its engineering services were considered a "positive factor[]" supporting the merger.

On March 29, 2021, after the market closed, Canoo revealed the Company would no longer focus on its engineering services line, which had been touted in the merger documents just three months earlier and formed the basis of Canoo's growth story. Discussions during the press conference also revealed that Canoo had decreased its focus on its plan to sell vehicles to consumers through a subscription model, and that contrary to prior statements Canoo did not have partnerships with original equipment manufacturers and no longer engaged in the previously announced partnership with Hyundai. On this news, Canoo's stock price fell $2.50, or over 21%, to close at $9.30 per share on March 30, 2021.

Now, the U.S. Securities and Exchange Commission is investigating the Company. The investigation covers Hennessy's initial public offering and merger with Canoo, the Company's operations, business model, revenues, revenue strategy and customer agreements, earnings and other related topics, and the recent departures of certain of the Company's officers.

If you purchased shares of Canoo Inc. (GOEV) between August 18, 2020 and March 29, 2021, you have until June 1, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Canoo Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Robbins LLP Urges GOSS Stockholders to Contact the Firm for Information About the Class Action Against Gossamer Bio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gossamer Bio, Inc. (NASDAQ: GOSS) securities between June 16, 2025 and February 20, 2026. Gossamer is a clinical stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension (PH) associated with interstitial lung disease.For more information, submit a form, email att...

Robbins LLP Urges IBRX Stockholders to Contact the Firm for Information About the Class Action Against ImmunityBio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ImmunityBio, Inc. (NASDAQ: IBRX) securities between January 19, 2026 and March 25, 2026. ImmunityBio is a biotechnology company and ANKTIVA is the Company's lead biologic product. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? January 19, 2026 – March 25, 202...

Robbins LLP Reminds ALDX Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Case Against Aldeyra Therapeutics, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) securities between November 3, 2023 and March 16, 2026. Defendant Aldeyra describes itself as a “biotechnology company devoted to discovering innovative therapies designed to treat immune-mediated diseases.” Pertinent to this action is reproxalap, which is a novel reactive aldehyde species (RASP) inhib...
Back to Newsroom